Legend Biotech Files 6-K for Q4 2023 Results
Ticker: LEGN · Form: 6-K · Filed: Mar 11, 2024 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-report, 6-K
TL;DR
Legend Biotech dropped its Q4 2023 earnings report on 3/11/24. Check the 6-K for details.
AI Summary
Legend Biotech Corporation filed a Form 6-K on March 11, 2024, reporting its fourth quarter and full year 2023 results. The filing indicates the company's principal executive office is located at 2101 Cottontail Lane, Somerset, New Jersey. Legend Biotech is a foreign private issuer and files annual reports under Form 20-F.
Why It Matters
This filing provides investors with the latest financial and operational updates from Legend Biotech, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) providing an earnings release and does not contain significant new risk factors.
Key Players & Entities
- Legend Biotech Corporation (company) — Registrant
- 2101 Cottontail Lane, Somerset, New Jersey (location) — Principal executive office address
- March 11, 2024 (date) — Date of Report
- 001-39307 (other) — Commission File Number
- 20231231 (date) — Conformed Period of Report
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed by Legend Biotech Corporation to report its fourth quarter and full year 2023 results.
When was this filing submitted to the SEC?
The filing was submitted on March 11, 2024.
What is Legend Biotech Corporation's primary business address?
Legend Biotech Corporation's principal executive office is located at 2101 Cottontail Lane, Somerset, New Jersey.
Does Legend Biotech file an annual report on Form 20-F or 40-F?
Legend Biotech files its annual reports under cover of Form 20-F.
What period does the 'Conformed Period of Report' refer to?
The 'Conformed Period of Report' refers to the period ending December 31, 2023.
Filing Stats: 326 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-03-11 07:52:28
Filing Documents
- form6-kx4q23earningsrelease.htm (6-K) — 20KB
- a991earningsreleaseq42023.htm (EX-99.1) — 163KB
- pipeline3-7x24.htm (EX-99.2) — 1KB
- legendlogoa.jpg (GRAPHIC) — 7KB
- pipeline3-7x24001.jpg (GRAPHIC) — 127KB
- 0001801198-24-000011.txt ( ) — 369KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. LEGEND BIOTECH CORPORATION Date March 11, 2024 By s Ying Huang Name Ying Huang, Ph.D. Title Chief Executive Officer